Home›Stock Screener›Gujarat Terce Laboratories

Gujarat Terce Laboratories Share Price Today | Stock Price & Gujarat Terce Laboratories Share Screener

GUJTERC Pharmaceuticals
Live Share Price BSE
₹34.83
▼ -0.33 (-0.94%)
2026-10-05 00:00:00

As of October 5, 2026, the live Gujarat Terce Laboratories share price (BSE: GUJTERC) is ₹34.83, down 0.94% from the previous close, with shares trading between ₹34.51 and ₹36.88 in today's trading session, and a 52-week range of ₹30.90–₹52.78. Check Gujarat Terce Laboratories 52-week for the annual price range and momentum. Use the Gujarat Terce Laboratories stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Gujarat Terce Laboratories opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹10 and net income of ₹2, with EBITDA of ₹2, an operating margin of 16.0% and a profit margin of 20.0%.

Gujarat Terce Laboratories Market Cap ₹28.03 Cr.
GUJTERC P/E Ratio (TTM) 15.00
Gujarat Terce Laboratories P/B Ratio 3.50
EPS (TTM) ₹2.92
Dividend Yield -
Debt to Equity 0.14
GUJTERC 52 Week High ₹52.78
Gujarat Terce Laboratories 52 Week Low ₹30.90
Operating Margin 16.00%
Profit Margin 20.00%
GUJTERC Revenue (TTM) ₹10.00
EBITDA ₹2.00
Net Income ₹2.00
Total Assets ₹25.00
Total Equity ₹10.00

Gujarat Terce Laboratories Share Price Chart

Track the current stock price of Gujarat Terce Laboratories with an interactive chart. Analyse GUJTERC share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Gujarat Terce Laboratories stock quote in one place.

The quote of ₹34.83 sits between the 52-week low of ₹30.90 and the 52-week high of ₹52.78, and the latest session moved -0.94% from the previous close.

Gujarat Terce Laboratories Company Profile - Fundamental Screener

Screen Gujarat Terce Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for GUJTERC shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE499G01013.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE499G01013

Gujarat Terce Laboratories Balance Sheet Screener

Screen GUJTERC balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹25, up from ₹23 in 2025.

Latest statistics put total assets at ₹25 and shareholder funds at ₹10, with a leverage ratio of 0.14.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 25 23 23 29 27 22 23 19 20 24
Current Assets 14 12 11 16 16 12 12 9 10 13
Fixed Assets 3 4 4 4 4 3 2 2 2 6

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 4 4 4 5 6 3 2 2 2 8
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 10 7 7 7 9 8 11 11 10 10
Share Capital 8 7 7 7 7 7 7 7 7 7
Reserves & Surplus 2 -1 0 -1 1 0 4 3 3 3

Gujarat Terce Laboratories Income Statement Screener - Profit & Revenue Analysis

Screen Gujarat Terce Laboratories income statement and profit fundamentals. Analyze GUJTERC quarterly results. Gujarat Terce Laboratories reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2021-Jun, revenue was ₹10 and net profit was ₹2, equal to earnings per unit of ₹2.16, at an operating margin of 16%.

In that period expenses were ₹8, interest cost ₹0 and tax ₹0. The next period listed, 2021-Sept, shows revenue of ₹10 and net profit of ₹0.

Item 2021-Jun 2021-Sept 2020-Mar 2020-Jun 2020-Sept 2019-Mar 2019-Jun 2019-Sept 2019-Dec 2018-Dec

Revenue and Expenses

Revenue 10 10 10 5 7 8 7 11 10 8
Expenses 8 10 10 5 7 8 8 9 10 8

Operating Costs and Margins

EBITDA 2 1 0 0 0 0 -1 2 1 1
Operating Profit % 16.00% 5.00% -5.00% -8.00% 2.00% 2.00% -16.00% 17.00% 4.00% 8.00%
Depreciation 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax 2 0 0 0 0 0 -1 2 0 1
Tax 0 0 0 0 0 0 0 0 0 0
Net Profit 2 0 -1 0 0 0 -1 2 0 1
EPS 2.16 0.61 0.00 -0.60 -0.02 0.49 0.00 2.28 0.50 0.77

Gujarat Terce Laboratories Cash Flow Screener - Liquidity Fundamentals

Screen GUJTERC cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹2, and net cash flow was an inflow of ₹2.

Over the same period, investing activities provided ₹0 and financing activities provided ₹1.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 2 3 3 0 0 0 -2 -1 5 0
Investing Activities 0 1 -1 1 -1 0 0 0 1 0

Financing and Net Cash

Financing Activities 1 -3 -4 0 2 2 2 0 -5 0
Net Cash Flow 2 1 -2 1 0 1 0 -1 0 0

Gujarat Terce Laboratories Shareholding Pattern Screener

See Gujarat Terce Laboratories shareholding pattern with promoter, FII, and DII holdings. Check Gujarat Terce Laboratories promoter holding and ownership changes for GUJTERC on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 40.03%, foreign institutions 0.00%, domestic institutions 0.00% and the public 54.58%, spread across 13,750 shareholders.

The shareholder count was 13,750 in 2026-Mar, compared with 13,755 in 2026-Jun.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun

Promoter Holding

Promoter Holding 40.03% 40.03% 37.03% 37.03% 37.03% 40.03% 37.03% 37.03%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 54.58% 54.37% 59.34% 59.12% 58.49% 54.43% 59.92% 59.87%
Other Holding 5.39% 5.61% 3.63% 3.85% 4.48% 5.54% 3.05% 3.10%
Shareholder Count 13,750 13,755 13,764 13,804 13,812 13,812 13,203 13,394

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Gujarat Terce Laboratories. Gujarat Terce Laboratories dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Gujarat Terce Laboratories.

Gujarat Terce Laboratories Stock Index Membership - Nifty & Sensex

See which indices include Gujarat Terce Laboratories stock. Check GUJTERC index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Gujarat Terce Laboratories is not part of any tracked indices.
Only major market indices are tracked in our system.

Gujarat Terce Laboratories Market Events Screener - Corporate Actions

Get Gujarat Terce Laboratories corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Gujarat Terce Laboratories stock events that may affect GUJTERC share price, along with derivatives, futures and options activity and sector gainers.

12 corporate actions are listed, the most recent entry being Annual General Meeting dated August 21, 2026, with a record date of August 21, 2026.

It is followed by Quarterly Result Announcement dated August 7, 2026 and Quarterly Result Announcement dated May 29, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-08-21 2026-08-21 Annual General Meeting NA 4.57%
2026-08-07 2026-08-07 Quarterly Result Announcement NA 8.28%
2026-05-29 2026-05-29 Quarterly Result Announcement NA -0.69%
2026-02-04 2026-02-04 Quarterly Result Announcement NA -10.05%
2025-11-08 2025-11-08 Quarterly Result Announcement NA 0.50%
2025-08-21 2025-08-21 Annual General Meeting NA -11.91%
2025-08-11 2025-08-11 Quarterly Result Announcement NA -3.34%
2025-05-26 2025-05-26 Quarterly Result Announcement NA -2.57%
2025-02-04 2025-02-04 Quarterly Result Announcement NA -6.07%
2024-10-28 2024-10-28 Quarterly Result Announcement NA -9.08%
2024-09-17 2024-09-17 Annual General Meeting NA 42.75%
2024-04-25 2024-04-25 Extraordinary General Meeting NA 27.38%

Gujarat Terce Laboratories Competitors Screener - Peer Stocks Comparison

Screen GUJTERC competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 432,120 36.04 61,674 12.69% 11,565 36.68
Divis Laboratories 245,532 84.24 11,067 13.95% 2,568 51.70
Torrent Pharmaceuticals 181,333 84.71 13,886 20.34% 2,138 41.12
Zydus Life Science 114,284 25.27 27,658 17.64% 5,026 47.64
Cipla 108,576 32.50 29,045 2.24% 3,870 34.78
Laurus Labs 107,198 98.20 6,868 22.01% 890 58.70
Mankind Pharma 104,707 50.04 14,636 14.85% 1,938 61.75
Dr Reddys Laboratories 100,679 32.41 35,059 3.90% 4,158 53.84
Aurobindo Pharma 96,479 25.84 34,145 5.56% 3,503 50.30
Lupin 92,885 16.82 29,039 26.75% 5,356 31.59

Gujarat Terce Laboratories Company Announcements - News & Reports Screener

Screen GUJTERC latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated September 29, 2026.

The next most recent announcements are dated August 21, 2026 and August 21, 2026.

Date Update Actions
2026-09-29 Closure of Trading Window -
2026-08-21 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-08-21 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-08-21 Announcement under Regulation 30 (LODR)-Change in Directorate -
2026-08-21 Announcement under Regulation 30 (LODR)-Change in Directorate -
2026-08-08 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-07 Board Meeting Outcome for Outcome Of The Board Meeting Held On 7 August 2026 -
2026-08-07 Unaudited Standalone Financial Results Of The Company For The First Quarter Ended 30 June 2026 -
2026-08-01 Board Meeting Intimation for Approving The Unaudited Standalone Financial Results Of The Company For The First Quarter Ended On 30 June 2026 -
2026-07-30 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-07-28 41St AGM Of The Shareholders Of Gujarat Terce Laboratories Limited Will Be Held On 21St August 2026 At 12:00 Noon. -
2026-07-28 Reg. 34 (1) Annual Report. -
2026-07-14 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-06-25 Closure of Trading Window -
2026-06-03 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-06-01 Amendment To The Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive Information -
2026-05-30 Fixation Of Date Of 41St Annual General Meeting ("AGM") Of The Company For The Financial Year Ended 31 March 2026 To Be Held On Friday 21 August 2026 -
2026-05-30 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-05-29 Fixation Of Date Of 41St Annual General Meeting ("AGM") Of The Company For The Financial Year Ended 31 March 2026 To Be Held On Friday 21 August 2026 -
2026-05-29 Board Meeting Outcome for Outcome Of Board Meeting Held On 29 May 2026 -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹34.83, within a 52-week range of ₹30.90 to ₹52.78. The P/E ratio is 15.00 and the P/B ratio is 3.50, with earnings per unit of ₹2.92. Market capitalisation stands at ₹28.03 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 10 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.